Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses

[31] Jiang N(2012)Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: a systematic review and updated meta-analysis DARU J Pharm Sci. 19 e334-369

[32] Underwood L(2013)Selected pregnancy and delivery outcomes after exposure to antidepressant medication JAMA Psychiat 83 909-308

[33] Waldie K(2012)Do findings differ across research design? The case of antidepressant use in pregnancy and malformations J Popul Ther Clin Pharmacol 21 1001-396

[34] Souza SD(2017)Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies Br J Clin Pharmacol 44 291-394

[35] Peterson ER(2019)Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy Nicotine Tob Res 25 1160-463

[36] Morton S(2021)A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants Drug Saf 11 e0165122-12

[37] Schwalm M(2016)Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy Pharmacoepidemiol Drug Saf 4 1-18

[38] Miotti H(2016)Selective serotonin reuptake inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark PLoS ONE 47 1002-1907

[39] Hellard C(2015)Selective serotonin reuptake inhibitors (SSRIs) and the risk of congenital heart defects: a meta-analysis of prospective cohort studies J Am Heart Assoc 16 205-127

[40] Bounit L(2013)Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations Aust N Z J Psychiatry 13 75-28

[31] Jiang N(2012)Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: a systematic review and updated meta-analysis DARU J Pharm Sci. 19 e334-369

[32] Underwood L(2013)Selected pregnancy and delivery outcomes after exposure to antidepressant medication JAMA Psychiat 83 909-308

[33] Waldie K(2012)Do findings differ across research design? The case of antidepressant use in pregnancy and malformations J Popul Ther Clin Pharmacol 21 1001-396

[34] Souza SD(2017)Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies Br J Clin Pharmacol 44 291-394

[35] Peterson ER(2019)Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy Nicotine Tob Res 25 1160-463

[36] Morton S(2021)A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants Drug Saf 11 e0165122-12

[37] Schwalm M(2016)Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy Pharmacoepidemiol Drug Saf 4 1-18

[38] Miotti H(2016)Selective serotonin reuptake inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark PLoS ONE 47 1002-1907

[39] Hellard C(2015)Selective serotonin reuptake inhibitors (SSRIs) and the risk of congenital heart defects: a meta-analysis of prospective cohort studies J Am Heart Assoc 16 205-127

[40] Bounit L(2013)Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations Aust N Z J Psychiatry 13 75-28